Compugen Ltd. (USA) (NASDAQ:CGEN)

CAPS Rating: 3 out of 5

A biotechnology discovery company focused on discovering and licensing of product candidates to the drug and diagnostic industry.

Results 1 - 10 of 10

Recs

0
Member Avatar DrLinks (52.23) Submitted: 7/15/2013 12:19:30 AM : Outperform Start Price: $5.57 CGEN Score: +63.36

Like overall potential

Recs

0
Member Avatar creelon (< 20) Submitted: 1/27/2013 3:11:00 PM : Outperform Start Price: $5.61 CGEN Score: +49.06

new silicon-driven system for drug discovery. Focused on high return sectors.

Recs

0
Member Avatar bIlluminati (30.14) Submitted: 8/13/2012 1:33:19 PM : Underperform Start Price: $3.13 CGEN Score: -177.38

Still early in development. flow.Negative cash

Recs

0
Member Avatar kwf1hbf (< 20) Submitted: 6/22/2011 8:22:00 PM : Outperform Start Price: $3.82 CGEN Score: +107.61

great management and scientists

Recs

0
Member Avatar sandmanjg (< 20) Submitted: 4/4/2011 8:53:01 PM : Outperform Start Price: $4.99 CGEN Score: +54.94

Gilder pick ... the future of pharma development in-silico

Recs

0
Member Avatar runneil (< 20) Submitted: 7/13/2010 7:33:49 AM : Outperform Start Price: $3.75 CGEN Score: +88.17

in the Big Short one investor talked about investing a little to make a lot. in 28yrs of serious investing i've never seen a better risk/reward if one has risk capital. CGEN is not looking to make a drug winner but to make time to market of future drugs significantly less. See George Gilders latest comments.

Recs

0
Member Avatar kong777 (79.35) Submitted: 5/28/2010 1:49:41 PM : Outperform Start Price: $4.22 CGEN Score: +59.70

The breakthrough scientific company. The new paradigm of the drug discovery platform

Recs

0
Member Avatar stuch (< 20) Submitted: 2/25/2010 7:54:00 PM : Outperform Start Price: $4.39 CGEN Score: +52.92

its technologyand sound management of finances

Recs

0
Member Avatar ztaylor40 (90.80) Submitted: 12/30/2009 11:05:27 PM : Outperform Start Price: $4.95 CGEN Score: +30.88

Show me the money!

Recs

0
Member Avatar Student4Ever (< 20) Submitted: 12/29/2009 8:01:14 AM : Outperform Start Price: $5.09 CGEN Score: +26.02

With the cancer drug + the Pfizer connection, this company has only upwards to go.

Results 1 - 10 of 10

Featured Broker Partners


Advertisement